Interrogating Neurofilament as a Marker of Disease Activity & Treatment Response

Time: 8:30 am
day: Day One


  • Assessing data from tofersen studies to explore the potential utility of neurofilament to enrich or stratify study populations
  • Evaluating the relationship between treatment-induced reductions in neurofilament and clinical outcome measures
  • Exploring neurofilament as an early marker of disease activity in presymptomatic mutation carriers